Author

Udo S. Gaipl

Friedrich-Alexander-Universität Erlangen-NürnbergORCID 0000-0001-6375-5476Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:database / resource· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Benjamin FreyiD· 2 shared Hu MaiD· 2 shared Jian‐Guo ZhouiD· 2 shared Minjun CheniD· 2 shared Shixiang WangiD· 2 shared Ariful Haque AbiriD· 1 shared Dimitrios MougiakakosiD· 1 shared Dirk MielenziD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Benjamin FreyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Glycolytic flux sustains human Th1 identity and effector function via STAT1 glycosylation

Ariful Haque Abir, Julia Benz, Benjamin Frey, Heiko Bruns, Gerhard Krönke, Udo S. Gaipl, Kilian Schober, Dimitrios Mougiakakos, Dirk Mielenz

This study shows glycolytic flux supports human Th1 cell identity and effector function through STAT1 O-glycosylation, with inhibition of glycolysis or O-glycosylation reducing IFN-gamma production.

Life Science Alliance · Oct 22, 2025Peer-reviewedImmunology

ImmunoFusion: A Unified Platform for Investigating RNA-seq-Derived Gene Fusions in Cancer and Immunotherapy

YanKun Zhao, Shixiang Wang, Shensuo Li, Minjun Chen, Su‐Han Jin, Udo S. Gaipl, Hu Ma, Jian‐Guo Zhou

ImmunoFusion integrates RNA-seq-derived gene fusion data across cancer types with tumor microenvironment and clinical outcomes to identify fusion-driven immunotherapy biomarkers.

bioRxiv · Jun 5, 2025 · PreprintBioinformatics

TCCIA: A Comprehensive Resource for Exploring CircRNA in Cancer Immunotherapy

Shixiang Wang, Yi Xiong, Yihao Zhang, Haitao Wang, Minjun Chen, Jianfeng Li, Peng Luo, Yung‐Hung Luo, Markus Hecht, Benjamin Frey, Udo S. Gaipl, Xuejun Li, Qi Zhao, Hu Ma, Jian‐Guo Zhou

TCCIA integrates circRNA profiles, immunotherapy response data, and clinical outcomes to explore circRNA roles in cancer immunotherapy.

Journal for ImmunoTherapy of Cancer · Jan 1, 2024Peer-reviewedBioinformatics